Novel CXC receptor ligands from GCP2
Summary
USPTO published patent application US20260092091A1 for novel polypeptide ligands of CXCR1 and/or CXCR2 derived from GCP2. The application (No. 19120219) was filed October 11, 2023, by inventors Kouvatsos, Day, Dell'Accio, and Caxaria. The invention covers polynucleotides encoding the ligands, compositions, and uses thereof.
What changed
USPTO published a patent application for novel CXC receptor ligands derived from GCP2 (Granulocyte Chemotactic Protein 2). The application claims polypeptide ligands targeting CXCR1 and CXCR2 receptors, along with encoding polynucleotides and pharmaceutical compositions. The filing (US20260092091A1) has a priority date of October 2023.
Patent applications do not create compliance obligations. For companies in pharmaceutical or biotechnology sectors, this publication establishes prior art as of the filing date. Entities developing similar CXC receptor modulators should review the claims to assess potential freedom-to-operate issues. No action is required unless the application becomes relevant to ongoing R&D programs or product development.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CXC RECEPTOR LIGANDS
Application US20260092091A1 Kind: A1 Apr 02, 2026
Inventors
Nikolaos KOUVATSOS, Anthony DAY, Francesco DELL'ACCIO, Sara CAXARIA
Abstract
The present invention relates to novel polypeptide ligands of CXCR1 and/or CXCR2 which are derived from GCP2. The invention also concerns polynucleotides encoding the polypeptide ligands, uses of the polypeptide ligands and compositions comprising the polypeptide ligands.
CPC Classifications
C07K 14/521 A61P 19/02 A61K 38/00
Filing Date
2023-10-11
Application No.
19120219
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Peptides (C07K) publishes new changes.